Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRenishaw Regulatory News (RSW)

Share Price Information for Renishaw (RSW)

Share Price is delayed by 15 minutes
Get Live Data
5,270.00    -120.00 (-2.23%)
Bid:
5,260.00
Ask:
5,275.00
Spread: 15.00 (0.285%)
Market Cap: £3.83b
RSW Live PriceLast checked at - London Stock Exchange

Intraday Renishaw Share Chart

Interim Management Statement

15 May 2012 07:00

RNS Number : 3075D
Renishaw PLC
15 May 2012
 



 

Renishaw plc

Interim Management Statement

15th May 2012

 

 

Renishaw plc issues the following Interim Management Statement covering the period from 1st January 2012 to 14th May 2012. Financial information in this announcement relating to the current year is unaudited.

 

Group trading activity

 

Revenue for the third quarter ended 31st March 2012 was £81.6m, compared with £78.4m for the comparable period last year, an increase of 4%. Cumulative revenue for the 9 months to 31st March 2012 of £228.8m was 9% ahead of the £210.6m for the comparable period.

 

During the period we experienced growth in Europe, UK and the Americas. Sales to the USA, our biggest single market, are going well with revenue above the comparable period. In the Far East, our biggest geographical market, revenue in the third quarter was a little below the level of last year, however activity is picking up and we are expecting revenue for the full year to be ahead of last year. 

 

Profit before tax for the third quarter amounted to £21.4m compared with £25.2m last year and for the 9 months to 31st March 2012 amounted to £52.6m compared with £60.5m last year. As stated in the half year report, this reflects the impact of continued investment in staff and infrastructure to support future growth.

 

Metrology

 

Revenue in the Group's metrology sector for the 9 months amounted to £211.7m compared with £196.3m for the comparable period last year, an increase of 8%. This business sector is benefiting from the global investment demand for production systems in the automotive, civil aviation, agriculture, energy and consumer electronics sectors, and is starting to experience growth in the wider electronics market. New products continue to be introduced into the market. The RESOLUTE™ absolute optical encoder is now compatible with Mitsubishi's Melservo-J4 range of servo amplifiers, which are regularly used in industries such as electronic assembly. An updated UCC2-2 CMM controller was also released along with the next software version of UCCsuite, version 4.8. In April 2012 we were pleased to receive the Queen's Award for Enterprise 2012 in the Innovations Category for the SP80 ultra-high accuracy analogue scanning probe. This is the Company's fifteenth Queen's Award.

 

Healthcare

 

In our healthcare business sector, revenue was £17.1m compared with £14.3m last year, an increase of 20%. Our Spectroscopy product line introduced the RA800-series of OEM benchtop instrument solutions providing research grade Raman microscopy performance with simple-to-use software for materials analysis solutions across a wide range of application areas.

 

Group developments

 

During this period the Group established a new subsidiary in Mexico to provide local support and to expand our marketing activities in this growing market. In February 2012 the Group acquired Thomas Engineering, a company based in Canada, which distributes products for the Group's subsidiary company Measurement Devices Ltd. In April 2012 the Group acquired R&R Sales LLC, a USA-based supplier of fixtures for the global measurement and inspection market. This will support the Group's increasing focus on metrology system sales to end users, such as its new Equator Gauge, which requires fixturing products. It also provides the opportunity for R&R to expand its revenue, which is currently mainly USA-based, through Renishaw's global marketing and distribution infrastructure. The aggregate cash consideration for these two acquisitions amounted to £3.2m plus additional amounts dependent on performance over future specified time periods.

 

Following the purchase of the property at Miskin, South Wales, the Group has completed the refurbishment of 62,500 sq ft and new machinery is currently being commissioned to commence production at the site. This provides for additional manufacturing capacity to accommodate growing demand for the Group's products, including additive manufacturing machines which are scheduled to commence production from the beginning of 2013.

 

 

 

Financial position

 

The Group maintains a strong balance sheet with net cash balances of £33.7m at 31st March 2012, which includes an escrow account of £11.3m relating to the provision of security for the Group's defined benefit pension scheme. 

 

Outlook

 

Despite continuing global macroeconomic uncertainties, we have experienced good growth over the year to date and are starting to see signs of an upturn in the electronics market. The final quarter has started well with activity levels in April ahead of the comparable period last year. We currently expect that the Group's adjusted profit before tax for the year to 30th June 2012 will recover the year-to-date shortfall and should be a little higher than the adjusted profit before tax of £80.4m for the year to 30th June 2011. The Board continues to view the future with confidence.

 

 

Notes:

 

1. The 2011 figures as quoted have been restated to include the results of Measurement Devices Ltd.

 

2. Renishaw will be announcing its year end results to 30th June 2012 on 25th July 2012.

 

 

 

Sir David McMurtry CBE, RDI, FREng, FRS, CEng, FIMechE

Chairman and Chief Executive

 

15th May 2012

 

Renishaw plc

Registered office New Mills, Wotton-under-Edge, Gloucestershire, GL12 8JR

Registered number 1106260

Telephone number 01453 524524

Website www.renishaw.com

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSAIMATMBJBBTT
Date   Source Headline
22nd Sep 20203:11 pmRNSReplacement Director/PDMR Shareholding
22nd Sep 20202:19 pmRNSDirector/PDMR Shareholding
8th Sep 20204:35 pmRNSDirector/PDMR Shareholding
1st Sep 20207:00 amRNSAnnual Financial Report
27th Aug 20207:00 amRNSDirector/PDMR Shareholding
17th Aug 20203:15 pmRNSDirector/PDMR Shareholding
13th Aug 20207:00 amRNSFinal Results
6th Aug 202010:00 amRNSNotice of Results
17th Jul 20208:06 amRNSTrading Statement
26th Jun 20201:08 pmRNSDirector/PDMR Shareholding
24th Jun 20203:35 pmRNSDirector/PDMR Shareholding
22nd Jun 20204:17 pmRNSDirector/PDMR Shareholding
10th Jun 20202:00 pmRNSDirector/PDMR Shareholding
5th Jun 20207:00 amRNS2020 Final Dividend
12th May 20207:00 amRNSTrading Statement
4th May 202012:00 pmRNSDisclosure of Rights Attached to Equity Shares
2nd Apr 20204:30 pmRNSStatement re 2019 AGM resolution votes
25th Mar 20204:28 pmRNSStatement re Interim dividend
6th Mar 20209:36 amRNSDirector/PDMR Shareholding
27th Feb 20204:47 pmRNSStatement re Interim dividend
30th Jan 20207:00 amRNSHalf-year Report
29th Jan 20205:45 pmRNSChange in Director's Responsibilities
20th Jan 202012:00 pmRNSNotice of Half-year Results
17th Jan 20209:47 amRNSHolding(s) in Company
24th Oct 20193:37 pmRNSResult of AGM
15th Oct 20197:00 amRNSTrading Statement
30th Aug 20193:00 pmRNSPurchase of Shares by Profit Share Trust
21st Aug 20197:00 amRNSAnnual Financial Report
1st Aug 20197:00 amRNSFinal Results
16th Jul 20193:00 pmRNSNotice of Results
25th Jun 20197:00 amRNSDirectorate Change
14th May 201910:00 amRNSDirector Declaration
14th May 20197:00 amRNSTrading Statement
27th Mar 201911:36 amRNSDirector/PDMR Shareholding
22nd Mar 20199:48 amRNSDirector/PDMR Shareholding
21st Mar 20197:00 amRNSTrading Statement
12th Mar 20194:00 pmRNSNotice of Investor Day
31st Jan 20197:00 amRNSHalf-year Report
15th Jan 20193:00 pmRNSNotice of Half-year Results
19th Dec 201810:07 amRNSDirector/PDMR Shareholding
29th Oct 20189:56 amRNSDirector/PDMR Shareholding
23rd Oct 201810:02 amRNSDirector/PDMR Shareholding
22nd Oct 201810:43 amRNSDirector/PDMR Shareholding
18th Oct 20184:02 pmRNSResult of AGM
18th Oct 20187:00 amRNSTrading Statement
23rd Aug 20182:00 pmRNSPurchase of Shares by Profit Share Trust
21st Aug 20187:00 amRNSAnnual Financial Report
3rd Aug 201812:00 pmRNSDirector/PDMR Shareholding
2nd Aug 20183:00 pmRNSDirector Declaration
26th Jul 20187:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.